Related Experiment Video
Updated: Jul 6, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Therapeutic interventions favorably influencing delayed and slow graft function in kidney transplantation: mission
Patrick Peeters1, Raymond Vanholder
1Renal Division, Department of Internal Medicine, University Hospital Gent, Belgium. patrick.peeters@ugent.be
Abstract:
Dialyzed delayed graft function (DGF) and nondialyzed slow graft function (SGF) both determine a large portion of the negative impact on patient and graft survival, on early acute rejection incidence, on tubulointerstitial fibrosis/tubular atrophy, and on graft function. In an era where expanded-criteria donors, including older donors, and non-heart beating donors are used to overcome organ shortage, the long-term results of kidney transplantation are influenced by the events occurring within the first 24 hr before and after the transplantation procedure. The ischemia-reperfusion injury is initiated in the brain-death donor and continues during preservation and engraftment of the transplant. The determinants of this DGF/SGF complex intervene in five chronologically related stages--donor tissue quality, brain death and related stress, preservation variables, immune factors, and recipient variables. For each of these five stages, therapeutic interventions or preventive measures are capable of partially reversing the expected dismal outcome of DGF/SGF; these measures are discussed in this article. Donor selection and pharmacologic modulations do have an effect on DGF/SGF.
Insights
Dialyzed delayed graft function (DGF) and slow graft function (SGF) significantly impact kidney transplant survival and outcomes. Interventions targeting donor quality, preservation, and recipient factors can mitigate these negative effects.
Area of Science:
- Nephrology
- Transplantation immunology
- Surgical outcomes
Background:
- Delayed graft function (DGF) and slow graft function (SGF) negatively affect kidney transplant survival and early outcomes.
- Increased use of expanded-criteria and non-heart beating donors exacerbates DGF/SGF challenges.
- Ischemia-reperfusion injury, starting in the donor, significantly impacts transplant success.
Purpose of the Study:
- To review the determinants of DGF/SGF.
- To discuss preventive and therapeutic interventions for DGF/SGF.
- To highlight the impact of early events on long-term transplant results.
Main Methods:
- Review of factors influencing DGF/SGF.
- Analysis of five chronologically related stages: donor tissue quality, brain death, preservation, immune factors, and recipient variables.
- Discussion of therapeutic and preventive measures at each stage.
Main Results:
- DGF/SGF are influenced by donor quality, preservation, immune response, and recipient factors.
- Interventions at various stages can partially reverse adverse outcomes.
- Donor selection and pharmacologic modulations show a positive effect on DGF/SGF.
Conclusions:
- Managing DGF/SGF is crucial for improving kidney transplant outcomes.
- A multi-faceted approach addressing all five stages is necessary for effective prevention and treatment.
- Optimizing donor selection and employing targeted therapies can enhance graft survival.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
